Dive into the transformative world of Choose Your Horizon, where CEO Mark Holland is leading the charge in at-home psychedelic therapy. Focusing on mental wellness through ketamine treatment, the company aims to reshape the landscape of mental health care, offering hope and healing to those battling anxiety, depression, and PTSD. Uncover their strategy, growth, and passion for making a significant impact in healthcare.

Funding Round Details

Choose Your Horizon logo
Company: Choose Your Horizon
Security Type: Equity - Common
Valuation: $14,865,000
Min Investment: $280
Platform: StartEngine
Deadline: Mar 31, 2024
View Deal

In your own words, how would you describe your company?

Choose Your Horizon is a mental wellness company offering at-home psychedelic therapy for anxiety, depression, and PTSD through telemedicine provided by certified medical experts and trained facilitators. The business is developing best-in-class digital, psychedelic-orientated, customer journeys and patient protocols.

What inspired you to take the leap and start this company?

We were inspired to start the company after seeing the positive impact that ketamine therapy had on their own lives. Once you understand the history, the passion of those involved, and the body of clinical research already in existence and in progress, it’s difficult not to be compelled by the radical, positive impact these medicines can provide now and in the future.

What is ketamine, and what makes it so exciting?

Ketamine therapy is a rapidly growing field with the potential to revolutionize the way we treat mental illness. It works by blocking NMDA receptors in the brain, which leads to several therapeutic effects, including reduced symptoms of anxiety, depression, and PTSD. It also demonstrates positive effects on BDNF creation in the brain, which, among other mechanisms, helps create an environment of positivity and the ability to adapt positive changes into an individual’s life.

Where does ketamine stand in terms of regulation?

Ketamine therapy for mental illness is still in its early stages of development and is not yet FDA-approved. However, it is legal to use ketamine off-label for the treatment of mental illness. A growing body of evidence demonstrates positive outcomes for KAT ( Ketamine Assisted Therapy). Like all medications, it is important to build safety parameters into protocols to ensure patients receive the best standard of care. We have an amazing team of medical professionals who work to put a big emphasis on safety and patient outcomes in our medical protocols and services. 

You already have one exit under your belt. Can you tell us what you learned from building that company and what lessons you will take with you in growing Choose Your Horizon?

Growing early-stage healthcare businesses can be very complex, with many unexpected challenges and lessons. The most profound lesson has been the power of unwavering passion and purpose. Witnessing the positive impact we can have on patients’ lives is always the motivation to keep pushing through roadblocks. Finding something you care about then shifts the importance onto building a strong and dedicated team with shared beliefs in the potential to revolutionize healthcare. This previous experience has not only shaped the current business but also forged a deep understanding of how much effort it takes to break through the clutter and be able to improve the lives of others. In Choose Your Horizon, there is never a dull moment, from navigating the complex regulatory landscape to learning the language of insurance, every day has been a steep learning curve. The journey is far from over, but the lessons learned will serve as a compass, guiding the way toward a future where transformative mental healthcare is accessible, affordable, and truly transformative.

Is there anything you want investors to know about you or your company that they can’t find on your raise page?

The founders and the entire team are passionate about mental health and believe that ketamine and psychedelic therapy have the potential to help millions of people. We are committed to building a successful company that will make ketamine therapy more accessible and affordable.

If we talk again in 12 months, what milestones will you have achieved?

Choose Your Horizon grew our revenue 10x YoY in 2023. We are currently serving 20 states across the US and plan to be nationwide by the end of 2024. We have been working on and plan to be enrolled as an in-network service offering with our first cohort of 3 insurance providers covering 5-10 states. The company also plans to expand its team and raise additional funding.